The effect of high DHA/EPA PUFA and ascorbic acid in the treatment of refractory epileptic patients
Phase 2
Recruiting
- Conditions
- seizure.Epilepsy and recurrent seizures
- Registration Number
- IRCT20240220061057N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Epileptic patients who take at least two antiepileptic drugs but have had at least one seizure in the last 6 months.
Patients are at least 18 years old
Willingness to participate in the study
Exclusion Criteria
pregnancy
chronic kidney disease
history of MI or vascular interventions
history of renal stone
use of anticoagulants
history of allergy to ascorbic acid or DHA/EPA PUFA
history of familial or acquired dyslipidemia
The patient unwillingness to continue the combined treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method